Breaking New

Canada approves Astra-Zeneca Covid vaccine, to receive 5 lakh doses from India

Canada on February 26 approved AstraZeneca’s Covid-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week.

The vaccine is the third to be approved by Health Canada following the December approval of vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc.

“With Pfizer, Moderna, and now AstraZeneca, Canada will get more than 6.5 million doses before the end of March,” Prime Minister Justin Trudeau told reporters. “And there will be tens of millions more doses to come between April and June.”

Canada has ordered 20 million doses of the vaccine from AstraZeneca, and is due to receive 1.9 million through COVAX – the international initiative set up to provide equitable access to vaccines – in the first half of the year.

On Friday, Canada said it had secured an additional 2 million doses through its agreement with Verity Pharmaceuticals Canada Inc and the Serum Institute of India.

The Gulf Indians

Recent Posts

The SC order on Scheduled Caste Status of Dalit Muslim and Christian converts is Unconstitutional and Hasty.

By Joseph Maliakan You scratch an Indian, the caste comes out , irrespective of whether…

1 week ago

VBSA Bill 2025 : Goodbye to Autonomy of States in Higher Education

By Joseph Maliakan The Viksit Bharat Shiksha Adhishthan ( VBSA) ,Bill 2025 to replace the…

2 weeks ago

Crowe Mak Ghazali Founder Dr.Davis Kallukaran features in list of top 10 Chartered Accountants in Kerala

Kochi: A prominent NRI who is known for his corporate finance expertise and association with…

3 weeks ago

The SC order in the NCERT textbook case Impinge on Academic Freedom

By Joseph Maliakan As a reporter who has witnessed the continuous erosion of academic freedoms…

3 weeks ago

High-level CEPA seminar gives fillip to Oman-India economic ties

KOCHI: The significance of the Comprehensive Economic Partnership Agreement (CEPA) as a catalyst to boost…

4 weeks ago

This website uses cookies.